Evidence Synthesis
ORIBEVER Sees Strong Revenue Growth Amid Declining Daily Volume and Revenue Growth ORIBEVER (ORIBEVER) accelerated its Gross Margin to 52.6% in the quarter, up from 6.04%.
Evidence Synthesis
Last synthesized: 5 Sept 2026, 06:03
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
ORIBEVER Sees Strong Revenue Growth Amid Declining Daily Volume and Revenue Growth ORIBEVER (ORIBEVER) accelerated its Gross Margin to 52.6% in the quarter, up from 6.04%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 52.6 % | 6.04 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 6.04 % | 2.61 | ▲ |
| REVENUE_GROWTH_YOY | 16.5 % | 470.7 | ▼ |
| PRICE_CHANGE_PERCENT | -0.261 % | — | - |
| DAILY_VOLUME | 655 shares | 1,342 | ▼ |
| CLOSE_PRICE | 172.1 INR | 172.55 | ▼ |